100% Quality Guarantee
PhD-Level Technical Support
CHIKV Spike glycoprotein E2 Recombinant Protein (C-His)
Key Features

CHIKV Spike glycoprotein E2 Recombinant Protein (C-His) (GXRP07994)

SKU GXRP07994
Product Type Recombinant Protein
Species CHIKV
Expression System Mammalian cells
Tag C-His
$577 - $4,138

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

CHIKV Spike glycoprotein E2 Recombinant Protein (C-His)

CHIKV Spike glycoprotein E2 Recombinant Protein (C-His) is a recombinant protein expressed in mammalian cells, spanning Ser326-Gln666, with a C-terminal His tag. Predicted molecular weight: 41.26 kDa. Purity: >90% as determined by SDS-PAGE. Supplied lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol. Applications: ELISA, immunogen, SDS-PAGE and Western blot. Chikungunya virus (CHIKV) is an arthropod-borne alphavirus that causes Chikungunya fever, a re-emerging disease characterized by high fever, rash, and arthralgia. The E2 envelope glycoprotein is a structural protein that forms heterodimers with the E1 glycoprotein and is displayed on the viral surface as part of trimeric spike complexes. For research use only.

E2 is primarily responsible for receptor binding and host cell attachment, playing a key role in viral entry. As a major target of neutralizing antibodies, the E2 protein is widely used in serological diagnostics, vaccine development, and antiviral research.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose